# Predicting Treatment Response in Patients With OCD

> **NCT03993535** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 250 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** selective serotonin reuptake inhibitor

## Key facts

- **NCT ID:** NCT03993535
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-10
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03993535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03993535, "Predicting Treatment Response in Patients With OCD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03993535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*